Meanwhile, NK-1R antagonists (e.g., aprepitant, L-732,138, and L-733,060) block angiogenesis and the proliferation/migration of glioma cells by promoting apoptotic mechanisms in tumor cells [60,61]. Here, TACR1 is linked to glioma.